Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

PEP-NET · Predictive Epigenetics: Fusing Theory and Experiment

H2020Status: CLOSED1 November 201830 April 2023EU funding €4,062,700Call H2020-MSCA-ITN-2018

Epigenetic mechanisms of gene regulation are profoundly implicated in human health and disease. However, we are still far from a complete mechanistic understanding of many epigenetic processes. Without an understanding of mechanisms we cannot fully understand function in healthy cells, in disease states, and the effects and side effects of therapeutic interventions. This severely limits the development of healthcare strategies. Research in epigenetics has typically been based on experiments and not on theory. Although this has delivered large amounts of information, information alone is not sufficient. Further progress urgently needs a paradigm shift in the way in which we study epigenetics, namely: epigenetics needs mathematics. Mathematical models are essential to capture and understand the complex, dynamic and stochastic nature of epigenetic regulation. Models are immensely powerful because they identify unifying concepts and enable predictions of system properties. Modelling epigenetic processes not only holds the key to a deep mechanistic understanding, but also ultimately, to drug response predictions, patient-specific diagnoses and new therapies. One of the greatest challenges to uniting biology and mathematics is the barrier between disciplines, because education in each field has traditionally been mono-disciplinary. The PEP-NET ITN will overcome these barriers by uniting 16 outstanding European academic laboratories and companies who have pioneered the successful combination of theoretical and experimental epigenetics. PEP-NET will train a new cohort of 15 European researchers to combine quantitative experiments with predictive theoretical models, and to apply this knowledge to basic and applied questions of epigenetic function.

Consortium · 16 organisations

coordinator

HUMBOLDT-UNIVERSITAET ZU BERLIN

DE · €758,365

participant

DIAGENODE

BE · €512,640

partner

UNIVERSITY OF EAST ANGLIA

UK

participant

FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION

CH · €281,277

participant

MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)

DE · €252,788

participant

UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II

IT · €261,500

participant

KOBENHAVNS UNIVERSITET

DK · €297,522

participant

JOHN INNES CENTRE

UK · €303,173

partner

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA CORP

US

participant

CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET EN MEDECINE

FR · €274,802

participant

OSPEDALE SAN RAFFAELE SRL

IT · €261,500

partner

THE UNIVERSITY OF ADELAIDE

AU

participant

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

UK · €606,345

participant

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

DE · €252,788

partner

OXFORD BIODYNAMICS PLC

UK

partner

OXFORD NANOIMAGING LTD

UK

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.